Pregled bibliografske jedinice broj: 882054
Primary uterine and ovarian cancers in patients diagnosed with breast cancer: a case report
Primary uterine and ovarian cancers in patients diagnosed with breast cancer: a case report // HDIR-1 "From Bench to Clinic" First meeting with international participation
Zagreb, Hrvatska, 2010. (poster, međunarodna recenzija, sažetak, ostalo)
CROSBI ID: 882054 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Primary uterine and ovarian cancers in patients diagnosed with breast cancer: a case report
Autori
Butorac, Dražan ; Leniček, Tanja ; Levanat, Sonja ; Eljuga, LJerka ; Ljiljak, Dejan: ; Mazulin, Tihana ; Klarić, Petar ; Delač, Jadranka ; Sušac, Ilona ; Grbavac, Ivan ; Eljuga, Damir
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, ostalo
Skup
HDIR-1 "From Bench to Clinic" First meeting with international participation
Mjesto i datum
Zagreb, Hrvatska, 24.09.2010
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
primary uterine cancer ; ovarian cancer ; breast cancer
(Primary uterine cancer ; ovarian cancer ; breast cancer)
Sažetak
Previous large studies suggest that, among breast cancer survivors, the risk of developing second primary nonmammary neoplasms is higher than in the general population. Our patient, a 47-year-old female patient with a positive familial history of breast cancer, was diagnosed with breast cancer nine years ago. After a mastectomy she was treated with irradiation and chemotherapy. Subsequently, a tamoxifen citrat therapy was introduced because of the positive immunohistochemical test results of estrogens and progestogenes tumour receptors. Almost a decade after she was admitted to the gynecology ward because of vaginal bleeding. A hysterectomy with a bilateral oophorectomy was performed. Pathohistological analyses revealed an endometrioid adenocarcinoma of the endometrium synchronous with clarcellular carcinoma of the one ovary (FIGO III). No gene mutations of BRCA1 and BRCA2 were detected. Although BRCA1 and BRCA2 founder mutations predispose a specific subset of patients to carcinoma of the breast and ovary, the majority of these cancers are sporadic. Furthermore, it can be argued that radiotherapy, adjuvant chemotherapy and tamoxifen are associated with the development of second primary nonmammary neoplasms, especially in the breast cancer population in which these modalities are a part of the treatment. Even though the risk of individual second primary cancers cannot be reliably assessed due to today’s limited knowledge, preventive strategies, continued monitoring and early detection of second neoplasms may be wise precautions for this patient population.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
KBC "Sestre Milosrdnice"
Profili:
Tanja Leniček
(autor)
Damir Eljuga
(autor)
Dejan Ljiljak
(autor)
Dražan Butorac
(autor)
Sonja Levanat
(autor)
Jadranka Delač
(autor)
Petar Klarić
(autor)
Ivan Grbavac
(autor)
Ljerka Eljuga
(autor)